Patents by Inventor Pooja Manchandani

Pooja Manchandani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Administering Elagolix
    Publication number: 20230414618
    Abstract: The present disclosure relates to the use of GnRH receptor antagonists for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), or adenomyosis. In particular, the present disclosure describes methods for treating such gynecological disorders, where the methods involve administration of elagolix and may further involve co-administration of a CYP2B6 substrate (e.g., bupropion) or a CYP2C19 substrate (e.g., omeprazole) or a CYP3A4 substrate (e.g., ethinyl estradiol and/or levonorgestrel).
    Type: Application
    Filed: September 6, 2023
    Publication date: December 28, 2023
    Inventors: Mohamad Shebley, Ling Cheng, Pooja Manchandani
  • Methods of Administering Elagolix
    Publication number: 20220257597
    Abstract: The present disclosure relates to the use of GnRH receptor antagonists for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), or adenomyosis. In particular, the present disclosure describes methods for treating such gynecological disorders, where the methods involve administration of elagolix and may further involve co-administration of a CYP2B6 substrate (e.g., bupropion) or a CYP2C19 substrate (e.g., omeprazole) or a CYP3A4 substrate (e.g., ethinyl estradiol and/or levonorgestrel).
    Type: Application
    Filed: January 28, 2022
    Publication date: August 18, 2022
    Applicant: AbbVie Inc.
    Inventors: Mohamad Shebley, Ling Cheng, Pooja Manchandani